<DOC>
	<DOCNO>NCT02518932</DOCNO>
	<brief_summary>To ass modulate property cleave pentapeptide product GLP-1 amide .</brief_summary>
	<brief_title>The Effect VTC-G15 ( Pentapeptide Cleavage Product og GLP-1 ) Whole Body Glucose Metabolism Man</brief_title>
	<detailed_description>The investigator previously demonstrate infusion pentapeptide hyperglycemic clamp dog significantly increase glucose infusion rate necessary maintain stable hyperglycemia without significant difference insulin glucagon secretion . The present study 's aim examine whether also occur human . It may necessary examine dose response curve . Specifically , twenty healthy volunteer glucose infusion rate peptide infusion compare glucose infusion rate saline administration 4 hour hyperglycemic clamp , cross design ( mg/kg/min ) .</detailed_description>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Glucagon-Like Peptide 1</mesh_term>
	<mesh_term>Glucagon</mesh_term>
	<criteria>BMI 18.525 ; 3338 T2D T1D Hypoglycemic agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>